ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Jianguo Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1612-7375; OpenAlex author ID A5101141371. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper

Papers 4

ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway. Co-author DOI 10.1002/jcb.27155 ↗
Prognostic significance of CD4 and interleukin-22 expression in pancreatic cancer. Co-author PMID 31966872 ↗
High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1245/s10434-013-3322-x ↗
Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer. Co-author DOI 10.3748/wjg.v20.i19.5875 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jun Liu · 1 shared paper, 2018 · strength 0.11
- Paper ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway. DOI 10.1002/jcb.27155 ↗
Qianqian Xu · 1 shared paper, 2018 · strength 0.11
- Paper ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway. DOI 10.1002/jcb.27155 ↗
Fei Han · 1 shared paper, 2018 · strength 0.11
- Paper ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway. DOI 10.1002/jcb.27155 ↗
Haiping Zhao · 1 shared paper, 2017 · strength 0.07
- Paper Prognostic significance of CD4 and interleukin-22 expression in pancreatic cancer. PMID 31966872 ↗
Zhenxia Wang · 1 shared paper, 2017 · strength 0.07
- Paper Prognostic significance of CD4 and interleukin-22 expression in pancreatic cancer. PMID 31966872 ↗
Junwei Du · 1 shared paper, 2017 · strength 0.07
- Paper Prognostic significance of CD4 and interleukin-22 expression in pancreatic cancer. PMID 31966872 ↗
Yingxin Wei · 1 shared paper, 2014 · strength 0.04
- Paper High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-013-3322-x ↗
Congwei Jia · 1 shared paper, 2014 · strength 0.04
- Paper High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-013-3322-x ↗
Quan Liao · 1 shared paper, 2014 · strength 0.04
- Paper High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-013-3322-x ↗
Zhang Wen · 1 shared paper, 2014 · strength 0.04
- Paper High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-013-3322-x ↗
Yupei Zhao · 1 shared paper, 2014 · strength 0.04
- Paper High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-013-3322-x ↗
Lei You · 1 shared paper, 2014 · strength 0.04
- Paper High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-013-3322-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.